These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29446529)

  • 21. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 22. Glycemic variability indices determined by self-monitoring of blood glucose are associated with β-cell function in Chinese patients with type 2 diabetes.
    Zhang Y; Dai J; Han X; Zhao Y; Zhang H; Liu X; Li W; Ling H; Zhou X; Ying C
    Diabetes Res Clin Pract; 2020 Jun; 164():108152. PubMed ID: 32360707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary care physicians identify and act upon glycemic abnormalities found in structured, episodic blood glucose monitoring data from non-insulin-treated type 2 diabetes.
    Polonsky WH; Jelsovsky Z; Panzera S; Parkin CG; Wagner RS
    Diabetes Technol Ther; 2009 May; 11(5):283-91. PubMed ID: 19425876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.
    Fu C; Ji L; Wang W; Luan R; Chen W; Zhan S; Xu B
    J Endocrinol Invest; 2012 Mar; 35(3):269-73. PubMed ID: 21606668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.
    Guerci B; Drouin P; Grangé V; Bougnères P; Fontaine P; Kerlan V; Passa P; Thivolet Ch; Vialettes B; Charbonnel B;
    Diabetes Metab; 2003 Dec; 29(6):587-94. PubMed ID: 14707887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial.
    Young LA; Buse JB; Weaver MA; Vu MB; Mitchell CM; Blakeney T; Grimm K; Rees J; Niblock F; Donahue KE;
    JAMA Intern Med; 2017 Jul; 177(7):920-929. PubMed ID: 28600913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-monitoring of blood glucose among patients with diabetes in Jordan: Perception, adherence, and influential factors.
    Al-Keilani MS; Almomani BA; Al-Sawalha NA; Shhabat BA
    Diabetes Res Clin Pract; 2017 Apr; 126():79-85. PubMed ID: 28236721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-monitoring of blood glucose in type 2 diabetic patients in China: current status and influential factors.
    Yuan L; Guo X; Xiong Z; Lou Q; Shen L; Zhao F; Sun Z; Li J
    Chin Med J (Engl); 2014; 127(2):201-7. PubMed ID: 24438604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence and associated factors in self-monitoring of blood glucose in noninsulin-treated type 2 diabetes patients in the Valencia Community, Spain].
    Cano-Blanquer D; Cervera-Casino P; Peiró-Moreno S; Mateu-García M; Barreda-Aznar A;
    Rev Esp Salud Publica; 2013; 87(2):149-63. PubMed ID: 23775104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes.
    Rothman RL; Mulvaney S; Elasy TA; VanderWoude A; Gebretsadik T; Shintani A; Potter A; Russell WE; Schlundt D
    Pediatrics; 2008 Apr; 121(4):e912-9. PubMed ID: 18381520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of flash glucose monitoring on glycemic control in participants with diabetes mellitus: A meta-analysis of randomized controlled trials.
    Gao Y; Zhou M; Xu X; Chen WY
    J Diabetes Complications; 2022 Nov; 36(11):108314. PubMed ID: 36208566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial.
    Nishimura A; Harashima SI; Fujita Y; Tanaka D; Wang Y; Liu Y; Inagaki N
    J Diabetes Complications; 2017 Jan; 31(1):228-233. PubMed ID: 27653670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update.
    Poolsup N; Suksomboon N; Rattanasookchit S
    Diabetes Technol Ther; 2009 Dec; 11(12):775-84. PubMed ID: 20001678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a Combined Blood-Glucose- and ß-Ketone-Measuring Device Improves Glycemic Control in Insulin-Treated Patients With Diabetes: The Gold Plus Study.
    Ziegler R; Eichholz R; Schulz B
    J Diabetes Sci Technol; 2015 May; 9(6):1270-4. PubMed ID: 25986628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial.
    Wada E; Onoue T; Kobayashi T; Handa T; Hayase A; Ito M; Furukawa M; Okuji T; Okada N; Iwama S; Sugiyama M; Tsunekawa T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Kuwatsuka Y; Ando M; Goto M; Arima H
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32518063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention.
    Scavini M; Bosi E; Ceriello A; Giorgino F; Porta M; Tiengo A; Vespasiani G; Bottalico D; Marino R; Parkin C; Bonizzoni E; Cucinotta D
    Acta Diabetol; 2013 Oct; 50(5):663-72. PubMed ID: 22189755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.